| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2148* | 2021 |
| Effect of hydroxychloroquine in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 383 (21), 2030-2040, 2020 | 1471 | 2020 |
| Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial PW Horby, M Mafham, JL Bell, L Linsell, N Staplin, J Emberson, ... The Lancet 396 (10259), 1345-1352, 2020 | 803 | 2020 |
| Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort DT Arnold, FW Hamilton, A Milne, AJ Morley, J Viner, M Attwood, A Noel, ... Thorax 76 (4), 399-401, 2021 | 701 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 380* | 2021 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 240 | 2022 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10289), 2049-2059, 2021 | 227* | 2021 |
| The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular … E Avolio, M Carrabba, R Milligan, M Kavanagh Williamson, AP Beltrami, ... Clinical Science 135 (24), 2667-2689, 2021 | 148 | 2021 |
| Symptoms after COVID-19 vaccination in patients with persistent symptoms after acute infection: a case series DT Arnold, A Milne, E Samms, L Stadon, NA Maskell, FW Hamilton Annals of Internal Medicine 174 (9), 1334-1336, 2021 | 146* | 2021 |
| Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort J Tomlins, F Hamilton, S Gunning, C Sheehy, E Moran, A MacGowan Journal of Infection 81 (2), e59-e61, 2020 | 95 | 2020 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 77 | 2022 |
| Incidence, aetiology and outcome of community-acquired acute kidney injury in medical admissions in Malawi RDR Evans, U Hemmilä, A Craik, M Mtekateka, F Hamilton, Z Kawale, ... BMC nephrology 18, 1-9, 2017 | 74 | 2017 |
| Early warning scores do not accurately predict mortality in sepsis: a meta-analysis and systematic review of the literature F Hamilton, D Arnold, A Baird, M Albur, P Whiting Journal of Infection 76 (3), 241-248, 2018 | 67 | 2018 |
| Aerosol generating procedures: are they of relevance for transmission of SARS-CoV-2? F Hamilton, D Arnold, BR Bzdek, J Dodd, J Reid, N Maskell The Lancet. Respiratory Medicine 9 (7), 687, 2021 | 60 | 2021 |
| Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study DT Arnold, M Attwood, S Barratt, A Morley, KT Elvers, J McKernon, ... Emergency Medicine Journal 38 (7), 543-548, 2021 | 57 | 2021 |
| Aerosol emission from the respiratory tract: an analysis of aerosol generation from oxygen delivery systems FW Hamilton, FKA Gregson, DT Arnold, S Sheikh, K Ward, J Brown, ... Thorax 77 (3), 276-282, 2022 | 56 | 2022 |
| Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A Mendelian randomisation study FW Hamilton, M Thomas, D Arnold, T Palmer, E Moran, AJ Mentzer, ... PLoS Medicine 20 (1), e1004174, 2023 | 53 | 2023 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10320), 143-151, 2022 | 53 | 2022 |
| Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomized controlled trial FW Hamilton, T Lee, DT Arnold, R Lilford, K Hemming International Journal of Infectious Diseases 109, 114-117, 2021 | 51 | 2021 |
| Prognostication and monitoring of mesothelioma using biomarkers: a systematic review DT Arnold, D De Fonseka, FW Hamilton, NM Rahman, NA Maskell British journal of cancer 116 (6), 731-741, 2017 | 46 | 2017 |
David T ArnoldNIHR Doctoral Research Fellow, Bristol University在 bristol.ac.uk 的电子邮件经过验证
